Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Motoichiro Kato

From: Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug

Contact corresponding author